What the journal is
The IV Therapy Journal is a peer-reviewed journal for the IV therapy field: a central, trusted record of the safety data, standardized protocols and honest evidence appraisal that outpatient IV therapy has been missing.
Outpatient IV therapy has grown faster than its evidence base. Clinics deliver IV nutrient therapy, hydration and regenerative infusions every day, yet clinicians have had no shared literature on adverse events, dosing or protocols, and patients have had no reliable way to judge what is offered to them. This journal exists to close that gap — publishing work that is reviewed blind, disclosed in full, and held to the same standard whether it comes from a large research group or a single clinic.
An independent journal, founded and funded by Samael A. Tejada — not an association publication.
Scope
The journal publishes peer-reviewed work in four sections, plus one imprint. Promotional content is not published in any section.
- Clinical Protocols — formulations, dosing, patient selection, and administration practice.
- Safety & Standards — adverse events, compounding quality, osmolarity and compatibility, regulation, and clinic safety systems.
- Research Reviewed — original research, and evidence reviews that translate published studies for practicing clinicians.
- Practice & Industry — operations, training, staffing, and industry analysis, held to the same evidence discipline as the clinical sections.
Mitochondrial and regenerative medicine — mitochondrial, regenerative, and longevity interventions connected to infusion and clinic practice — grows as an imprint inside the journal: its own section, held to the same review standard. Early-stage topics are covered only as graded evidence reviews that state the evidence level plainly, name the regulatory status, and make no treatment recommendation beyond the evidence.
Who it serves
The journal is written for the people who run, direct, and study IV therapy: clinicians and infusion nurses, medical directors, clinic founders and operators, compounding and pharmacy partners, and the researchers building the field’s evidence base. Readers will find protocols they can evaluate, safety data they can benchmark against, and reviews that separate what is known from what is merely claimed.
How it works
Every manuscript is reviewed double-blind, checked for clinical safety and methods, and published with its authors’ disclosures in print. Commercial support never touches editorial decisions. The full framework is set out in the journal’s editorial policies, and the people responsible for the journal are listed on its masthead.